Sarda Proteins Ltd
NSE: BSE: 519242
₹84.48
(0%)
Sun, 05 Apr 2026, 00:38 pm
Market Cap145.8M
PE Ratio0
Dividend0
Process Industries
Agricultural Commodities/Milling
24.5KSarda Proteins Analysis
dividend
- Unable to evaluate Sarda Proteins's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Sarda Proteins's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Sarda Proteins is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Sarda Proteins is profitable, therefore cash runway is not a concern.
- Sarda Proteins is profitable, therefore cash runway is not a concern.
- Sarda Proteins has no debt, it does not need to be covered by operating cash flow.
- Sarda Proteins has no debt, it does not need to be covered by short term assets.
- Sarda Proteins's cash and other short term assets cover its long term commitments.
- Sarda Proteins has no debt compared to 5 years ago when it was 4.6%.
- Sarda Proteins has no debt, therefore coverage of interest payments is not a concern.
- Sarda Proteins has no debt.
- Low level of unsold assets.
management
- The average tenure for the Sarda Proteins board of directors is less than 3 years, this suggests a new board.
- The average tenure for the Sarda Proteins management team is less than 2 years, this suggests a new team.
misc
- Sarda Proteins is not covered by any analysts.
- BSE:519242 has not traded for 34 days.
past
- Sarda Proteins has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
- Sarda Proteins's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
- It is difficult to establish if Sarda Proteins has efficiently used its assets last year compared to the IN Consumer Retailing industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Sarda Proteins improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- Sarda Proteins has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Sarda Proteins has become profitable in the last year making it difficult to compare the IN Consumer Retailing industry average.
value
- Sarda Proteins is good value based on assets compared to the IN Consumer Retailing industry average.
- Sarda Proteins is overvalued based on earnings compared to the IN Consumer Retailing industry average.
- Sarda Proteins is overvalued based on earnings compared to the India market.
- BSE:519242 is flat (0%) underperforming the Consumer Retailing industry which returned 2.1% over the past month.
- BSE:519242 is flat (0%) underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800